Published January 4, 2026 | Version v1
Other Open

Does evidence suggest that the use of inhaled corticosteroids (ICS) in COPD increases the risk of pneumonia?

Authors/Creators

  • 1. Tripdatabase

Description

Evidence indicates inhaled corticosteroids in COPD are linked to an increased risk of pneumonia, with different formulations and disease severities potentially modifying the risk.

Files

9a75a99e-14f7-4d34-b978-8b0cabcfab96.pdf

Files (18.4 kB)

Name Size Download all
md5:0c8469f60f4d1c5d608d78904a123e06
18.4 kB Preview Download

Additional details

Related works

Is identical to
https://www.tripdatabase.com/ask/ics-use-in-copd-and-risk-of-pneumonia-9a75a99e-14f7-4d34-b978-8b0cabcfab96 (URL)